Icon

CARNEXIV (nda206030)- (200MG/20ML (10MG/ML))

CARBAMAZEPINE LUNDBECK PHARMS LLC
200MG/20ML (10MG/ML)
No Yes
2040-Jan-31 Expired
2023-Oct-07 None
None No
CARNEXIV is indicated as replacement therapy for oral carbamazepine formulations, when oral administration is temporarily not feasible, in adults with the following seizure types:  Partial seizures with complex symptomatology  Generalized tonic-clonic seizures  Mixed seizure patterns which include the above, or other partial or generalized seizures
0 0 0
Total Other Developers None
Drugs with Suitability No
200MG/20ML (10MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.